Food and Drug Administration (FDA) Funding This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Bioreactors for Reparative Medicine (R41/R42)
Funding Opportunity Number: RFA-HL-15-004 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.35093.83793.83893.839Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Oct 14, 2016Award Ceiling: Expected Number of Awards: 6Creation Date: Jul 24, 2014Funding Opportunity Description: Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop so...
Source: Grants.gov - July 24, 2014 Category: Research Tags: Health Source Type: funding

National Research Project to Assess State Agricultural Laws, Regulations, and Resources Related to Produce Safety (U01)
Funding Opportunity Number: RFA-FD-14-085 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: Consumer ProtectionFood and NutritionCFDA Number: 93.103Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-FDAClosing Date: Aug 26, 2014Award Ceiling: $3,000,000Expected Number of Awards: 1Creation Date: Jul 23, 2014Funding Opportunity Description: The Food and Drug Administration's (FDA), Office of Regulatory Affairs (ORA), Office of Partnerships (OP), is ...
Source: Grants.gov - July 24, 2014 Category: Research Tags: Consumer Protection Food and Nutrition Source Type: funding

Bioreactors for Reparative Medicine - SBIR Direct Phase II (R44)
Funding Opportunity Number: RFA-HL-15-017 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.28693.83793.83893.839Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Oct 14, 2016Award Ceiling: $750,000Expected Number of Awards: 19Creation Date: Jul 24, 2014Funding Opportunity Description: Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to ...
Source: Grants.gov - July 24, 2014 Category: Research Tags: Health Source Type: funding

Bioreactors for Reparative Medicine (R41/R42)
Funding Opportunity RFA-HL-15-004 from the NIH Guide for Grants and Contracts. Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop sophisticated and complex biomimetic culture systems that are capable of precise control of the cellular and 3-dimensional organ microenvironment, and which address the unique physiological dynamics of heart, lung and blood tissues. Projects awarded under this announcement should show evidence of developing or using good l...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2014 Category: Research Source Type: funding

Bioreactors for Reparative Medicine - SBIR Direct Phase II (R44)
Funding Opportunity RFA-HL-15-017 from the NIH Guide for Grants and Contracts. Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop sophisticated and complex biomimetic culture systems that are capable of precise control of the cellular and 3-dimensional organ microenvironment, and which address the unique physiological dynamics of heart, lung and blood tissues. Projects awarded under this announcement should show evidence of developing or using good l...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2014 Category: Research Source Type: funding

Bioreactors for Reparative Medicine (R43/R44)
Funding Opportunity RFA-HL-15-008 from the NIH Guide for Grants and Contracts. Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop sophisticated and complex biomimetic culture systems that are capable of precise control of the cellular and 3-dimensional organ microenvironment, and which address the unique physiological dynamics of heart, lung and blood tissues. Projects awarded under this announcement should show evidence of developing or using good l...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2014 Category: Research Source Type: funding

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)
Funding Opportunity Number: PAR-14-288 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.853Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) stat...
Source: Grants.gov - July 18, 2014 Category: Research Tags: Health Source Type: funding

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)
Funding Opportunity Number: PAR-14-289 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.853Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: May 07, 2017Award Ceiling: Expected Number of Awards: Creation Date: Jul 18, 2014Funding Opportunity Description: This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that ...
Source: Grants.gov - July 18, 2014 Category: Research Tags: Health Source Type: funding

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)
Funding Opportunity PAR-14-288 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS mission. An identified candidate, which has sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required for entry to the CREATE Bio Developmen...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2014 Category: Research Source Type: funding

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)
Funding Opportunity PAR-14-289 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS mission.An identified candidate, which has sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required for entry to the CREATE Bio Development ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2014 Category: Research Source Type: funding

Fostering Cooperation and Strengthening Medical Product Regulatory Systems in the Americas
The objective is to build upon existing cooperation to foster regulatory collaboration and strengthen regulatory capacity throughout the Americas in ways that provide benefit and contribution to the FDA regulatory and public health mission. This partnership aligns with FDA's domestic and global goals of addressing medical product safety and quality challenges. This Cooperative Agreement would support collaboration and investigation in the following areas: Developing and applying regional/global norms and standards ? Enable the sharing of scientific findings and data through expert meetings and technical consultations; ...
Source: Grants.gov - July 12, 2014 Category: Research Tags: Regional Development Source Type: funding

Request for Proposals: Making a Difference in Real-World Bioethics Dilemmas
Letters of intent for this cycle must be submitted online by August 1 at 4:00pm ET. However we strongly encourage applicants to submit letters of intent earlier, so that they have more time to respond to feedback from reviewers, if invited to submit a full application. Selected applicants will be invited to submit full applications online by Monday, September 15, with funding to start in early 2015. The Greenwall Foundation will fund a bioethics grants program, Making a Difference in Real-World Bioethics Dilemmas to support research to help resolve an important emerging or unanswered bioethics problem ...
Source: ScanGrants feed - June 26, 2014 Category: Research Authors: Greenwall Foundation Source Type: funding

CVM Vet-LRN Veterinary Diagnostic Laboratory Program - (U18)
Funding Opportunity Number: PA-12-194 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationEnvironmentFood and NutritionHealthNatural ResourcesScience and Technology and other Research and DevelopmentCFDA Number: 93.103Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Native American tribal organizations (other than Federally recognized tribal governments)Priv...
Source: Grants.gov - June 17, 2014 Category: Research Tags: Education Environment Food and Nutrition Health Natural Resources Science and Technology and other Research and Development Source Type: funding

Kidney Health Initiative (R18)
Funding Opportunity Number: RFA-FD-14-018 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Consumer ProtectionFood and NutritionHealthCFDA Number: 93.103Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-FDAClosing Date: Jun 30, 2014Award Ceiling: $500,000Expected Number of Awards: 1Creation Date: Jun 10, 2014Funding Opportunity Description: The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is ...
Source: Grants.gov - June 11, 2014 Category: Research Tags: Consumer Protection Food and Nutrition Health Source Type: funding

DoD Spinal Cord Injury Clinical Trial Award
Funding Opportunity Number: W81XWH-14-SCIRP-CTA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 30, 2014Award Ceiling: $0Expected Number of Awards: 3Creation Date: Jun 04, 2014Funding Opportunity Description: The SCIRP Clinical Trial Awar...
Source: Grants.gov - June 5, 2014 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding